Can you share a person you have managed who has experienced increased “off time” and motor fluctuations with CD/LD who might be an ideal patient for treatment with titratable formulations, including those based on scored, fractionable doses of CD/LD?
Published: July 27, 2022
Can you share a person you have managed who has experienced increased “off time” and motor fluctuations with CD/LD who might be an ideal patient for treatment with titratable formulations, including those based on scored, fractionable doses of CD/LD?
Can you share a person you have managed who has experienced increased “off time” and motor fluctuations with CD/LD who might be an ideal patient for treatment with titratable formulations, including those based on scored, fractionable doses of CD/LD?